Beyond its action on IgE neutralization followed by reduced signaling via FcεRI,15, 16, 17, 18, 19 which might contribute to the altered phenotypes of DCs and monocytes, omalizumab also resulted in the restoration of immunologic imbalance in severe allergic asthma patients.54 Here, FCER1A is linked to allergic asthma.